Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 8—August 2011
Research

Asymptomatic Primary Merkel Cell Polyomavirus Infection among Adults

Yanis L. Tolstov, Alycia Knauer, Jian Guo Chen, Thomas W. Kensler, Lawrence A. Kingsley1, Patrick S. Moore1, and Yuan Chang1Comments to Author 
Author affiliations: Author affiliations: University of Pittsburgh, Pittsburgh, Pennsylvania, USA (Y.L. Tolstov, A. Knauer, T.W. Kensler, L.A. Kingsley, P.S. Moore, Y. Chang); Qidong Liver Cancer Institute, Jiangsu, People’s Republic of China (J.G. Chen); Johns Hopkins University, Baltimore, Maryland, USA (T.W. Kensler)

Main Article

Table 3

Routine blood test characteristics for MCV seroconverters and controls matched by study visit among participants in the Multicenter AIDS Cohort Study, Pittsburgh, Pennsylvania, USA*

Characteristic MCV seroconverters
 Controls
 p value
No. tested Value No. tested Value
HIV positive, no. (%) 31 12 (38.7) 82 19 (23.2) 0.10
AIDS, subsequent, no. (%) 31 5 (16.1) 82 7 (8.5) 0.31
Hepatitis B surface antigen positive, no. (%) 30 0 (0) 81 1 (1.2) 1.00
Hepatitis B Core antigen antibody positive, no. (%) 30 19 (63.3) 81 36 (44.4) 0.08
RPR reactive, no. (%) 31 1 (3.2) 73 1 (1.4) 0.50
Leukocytes count, × 103/mm3 31 7174.2 75 6978.7 0.26
Erythrocytes count, × 103/mm3 31 5.1 75 5.2 0.13
Hemoglobin, g/dL 31 15.5 75 16.0 0.07
Hematocrit, % 31 46.7 75 47.7 0.15
Platelet count, × 103/mm3 31 247.3 75 259.6 0.14
Polymorphonuclear lymphocytes, % 31 58.7 75 58.1 0.61
Lymphocytes, % 31 32.6 75 32.9 0.83
Monocytes, % 29 5.9 72 5.5 0.22
Eosinophils, % 30 2.6 74 3.1 0.39
Atypical lymphocytes, % 29 1.2 71 1.1 0.56
Cytomegalovirus Ab titer 12 168.5 44 306.4 0.34
Rubella Ab titer 12 73.6 45 75.4 0.72
IgA, mg/dL 12 308.2 45 295.1 0.70
IgG, mg/dL 12 1,117.2 45 1151.5 0.93
IgM, mg/dL 12 178.8 45 172.5 0.75
CD4+, T-cells/μL 26 925.1 65 900.1 0.85
CD8+, T-cells/μL 26 637.7 65 564.5 0.22

*MCV, Merkel cell polyomavirus; RPR, rapid plasma reagin; Ab, antibody; Ig, immunoglobulin.

Main Article

1These authors contributed equally to this article.

Page created: August 15, 2011
Page updated: August 15, 2011
Page reviewed: August 15, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external